Skip over global navigation links
U.S. Department of Health and Human Services
  • Development of new anthrax vaccine underway with HHS support

    Project is the latest in the quest to protect health quickly in a bioterrorism attack

    A new anthrax vaccine that could be easier and faster to produce than the existing licensed product will undergo initial clinical studies through an agreement between HHS ASPR and Pfenex, Inc. of San Diego.


    Anthrax bacteria
Retrieving Data
Folder icon
  • This page last reviewed: September 04, 2015